PubRank

L Ose

Author PubWeight™ 73.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]. Tidsskr Nor Laegeforen 1974 2.33
2 Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 2001 2.08
3 The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol 1994 2.04
4 A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia. J Pediatr 1977 1.71
5 Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects. Eur J Clin Invest 1998 1.48
6 Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996 1.47
7 Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells. Exp Cell Res 1980 1.33
8 Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects. Arterioscler Thromb Vasc Biol 1996 1.19
9 Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes. Am J Med Genet 1983 1.18
10 Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet 1997 1.13
11 Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice. Am J Cardiol 2000 1.10
12 Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I. Am J Cardiol 1999 1.10
13 Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. Eur J Hum Genet 2001 1.07
14 Neonatal screening for hyperlipidaemia. Postgrad Med J 1975 1.05
15 Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis 2002 0.97
16 Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case. Scand J Clin Lab Invest 1996 0.97
17 Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene. PCR Methods Appl 1993 0.92
18 Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest 2006 0.89
19 Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells. Cytometry 1995 0.88
20 Paediatric screening for hypercholesterolaemia in Europe. Arch Dis Child 2011 0.88
21 Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro. Biochim Biophys Acta 1979 0.86
22 Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis 1994 0.86
23 Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study. Scand J Clin Lab Invest 1991 0.85
24 The binding of high density lipoproteins to isolated rat hepatocytes. Scand J Clin Lab Invest 1981 0.85
25 Results of intensive long-term treatment of familial hypercholesterolemia. Am J Cardiol 1996 0.84
26 A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000 0.84
27 Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia. Hum Genet 1995 0.83
28 A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol 1995 0.83
29 Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996 0.83
30 Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin. Int J Biochem 1981 0.82
31 Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia. Nutr Metab Cardiovasc Dis 2000 0.82
32 Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels. Am J Cardiol 2000 0.81
33 Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene. Scand J Clin Lab Invest 1994 0.81
34 Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway. Arterioscler Thromb Vasc Biol 1995 0.81
35 Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects. Eur J Clin Invest 2003 0.81
36 [Identification of syndromes using a combined computer and video program]. Tidsskr Nor Laegeforen 1990 0.81
37 Catabolism of (125-I)low density lipoproteins in isolated rat liver cells. Biochem Biophys Res Commun 1980 0.81
38 Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies. Am J Cardiol 1998 0.80
39 Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am J Med 2001 0.80
40 Molecular genetics of familial hypercholesterolaemia in Norway. J Intern Med 1997 0.80
41 Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection. Birth Defects Orig Artic Ser 1977 0.80
42 Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J Lipid Res 1997 0.80
43 Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype. Am J Med Genet 2001 0.79
44 Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system. Arterioscler Thromb 1991 0.79
45 Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein. J Lipid Res 1996 0.79
46 The effect of ammonia, chloroquine, leupeptin, colchicine and cytochalasin B on degradation of high density lipoproteins in isolated rat hepatocytes. Exp Cell Res 1980 0.79
47 Binding, uptake, and degradation of 125I-labelled high-density lipoproteins in isolated non-parenchymal rat liver cells. Scand J Gastroenterol 1981 0.79
48 Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia. Cytometry 1997 0.79
49 The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr 1998 0.79
50 Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol 1992 0.78
51 Hyperlipidemia: clinical clues in the first two decades of life. Johns Hopkins Med J 1977 0.78
52 Mutant transcripts of the LDL receptor gene: mRNA structure and quantity. Hum Mutat 1999 0.78
53 Screening for familial hypercholesterolaemia in relatives. Lancet 1995 0.78
54 Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia. J Intern Med 1999 0.78
55 Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study. J Int Med Res 1999 0.78
56 Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia. J Intern Med 2012 0.78
57 Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread. Eur J Clin Nutr 2004 0.78
58 The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia. Metabolism 1996 0.78
59 Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest 2006 0.77
60 No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women. Scand J Clin Lab Invest 1995 0.77
61 Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia? Acta Paediatr 2000 0.77
62 Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects. Nutr Metab Cardiovasc Dis 2001 0.77
63 A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects. Clin Genet 1992 0.77
64 Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals. Nutr Metab Cardiovasc Dis 2000 0.77
65 Low dose colestipol in adolescents with familial hypercholesterolaemia. Arch Dis Child 1996 0.77
66 Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene. J Lipid Res 1999 0.77
67 Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest 1996 0.77
68 Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine. Eur J Clin Pharmacol 1994 0.77
69 A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat 1996 0.76
70 Neonatal osteomyelitis caused by group B streptococci. Scand J Infect Dis 1976 0.76
71 Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females. Aesthetic Plast Surg 1995 0.76
72 [Application of gene technology in the diagnosis of familial hypercholesterolemia]. Tidsskr Nor Laegeforen 1997 0.76
73 Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women. J Intern Med 1995 0.76
74 Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop. Hum Genet 1993 0.76
75 Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function. Clin Chim Acta 2005 0.76
76 Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia. Clin Genet 1996 0.76
77 Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia. Hum Genet 1995 0.75
78 [Genetic screening and treatment in familial hypercholesterolemia]. Tidsskr Nor Laegeforen 2001 0.75
79 Letter: Usefulness of the xylose test for coeliac disease. Arch Dis Child 1976 0.75
80 Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo. Eur J Clin Invest 1992 0.75
81 [Familial hypercholesterolemia--prognosis and treatment]. Tidsskr Nor Laegeforen 2001 0.75
82 [The D-xylose-tolerance test as screeningtest for malabsorption diseases in children]. Tidsskr Nor Laegeforen 1974 0.75
83 Application of simple lipid treatment goals in patients with atherosclerotic disease. Nutr Metab Cardiovasc Dis 2000 0.75
84 Circulating dopamine-beta-hydroxylase (DbetaH) and catecholamines in a paediatric phaeochromocytoma. Clin Exp Pharmacol Physiol 1976 0.75
85 [What happens with patients after participation in a clinical trial?]. Tidsskr Nor Laegeforen 1997 0.75
86 [Diet and lipid status in pregnant women]. Tidsskr Nor Laegeforen 1995 0.75
87 Identification of the apo B-3500 mutation in the Norwegian population. Scand J Clin Lab Invest 1995 0.75
88 [Fraser's syndrome--cryptophthalmia]. Tidsskr Nor Laegeforen 1988 0.75
89 [Marketing of Carduran]. Tidsskr Nor Laegeforen 1989 0.75
90 [Treatment goals for blood lipids in high risk patients of atherosclerotic disease]. Tidsskr Nor Laegeforen 2001 0.75
91 The intracellular distribution of high density lipoproteins taken up by isolated rat hepatocytes. Biochim Biophys Acta 1980 0.75
92 [Finnish families in the town of Sør-Varanger. II. A study of blood pressure, height, weight, cholesterol, triglycerides and lipoprotein electrophoresis among Finnish men - combined effects of a change in diet]. Sykepleien 1975 0.75
93 [Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?]. Tidsskr Nor Laegeforen 1997 0.75
94 [Treatment of familial hypercholesterolemia]. Tidsskr Nor Laegeforen 1987 0.75
95 [Routine methods for fibrinogen determination]. Tidsskr Nor Laegeforen 1974 0.75
96 Psychological factors and cardiovascular disease. J Thromb Haemost 2004 0.75
97 Enhanced platelet activation in hyperhomocysteinemic individuals. J Thromb Haemost 2006 0.75
98 Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated with coronary heart disease. Scand J Clin Lab Invest 1976 0.75
99 Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group. Am J Cardiol 1995 0.75
100 [Hyperlipemia in children]. Tidsskr Nor Laegeforen 1977 0.75
101 Short report on DNA marker at candidate locus. Clin Genet 1993 0.75
102 Familial hypercholesterolemia. 50 years of research. Arteriosclerosis 1989 0.75
103 [Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]. Tidsskr Nor Laegeforen 1998 0.75
104 Is dietary intervention effective in post-transplant hyperlipidaemia? Nephrol Dial Transplant 1995 0.75
105 [Diagnosis and treatment of severe hyperlipidemia]. Tidsskr Nor Laegeforen 1997 0.75
106 Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia. Lancet 1975 0.75
107 [Iron status in postmenopausal women]. Tidsskr Nor Laegeforen 1994 0.75
108 [Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]. Tidsskr Nor Laegeforen 1989 0.75
109 Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA. Hum Mutat 1998 0.75
110 [D-xylose tolerance in malabsorption. Method of determination of D-xylose in serum and urine]. Tidsskr Nor Laegeforen 1973 0.75
111 A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects. Clin Genet 1992 0.75
112 Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia. Scand J Clin Lab Invest 1993 0.75
113 Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects. Clin Genet 1993 0.75
114 [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]. Tidsskr Nor Laegeforen 1992 0.75
115 [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III]. Tidsskr Nor Laegeforen 1993 0.75
116 [Cardiovascular diseases: we start with children]. Nord Med 1987 0.75
117 [The diet of patients with atherosclerotic disease compared with the standard diet in the population]. Tidsskr Nor Laegeforen 2000 0.75
118 Colestipol tablets in adolescents with familial hypercholesterolaemia. Acta Paediatr 1996 0.75
119 [Treatment of hypercholesterolemia in adults. A treatment program 1991]. Tidsskr Nor Laegeforen 1991 0.75
120 Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants. World Rev Nutr Diet 1994 0.75
121 Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition. Metabolism 1995 0.75
122 [Quality assurance in clinical trials. Problems related to patient information]. Tidsskr Nor Laegeforen 1992 0.75
123 [Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?]. Tidsskr Nor Laegeforen 1994 0.75
124 [Encephalitis associated with mycoplasma pneumoniae infection in children]. Tidsskr Nor Laegeforen 1975 0.75
125 Computed tomography of a tuberculous paravertebral abscess. Z Kinderchir 1988 0.75
126 Erratum to Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia. Clin Drug Investig 1995 0.75
127 [Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]. Tidsskr Nor Laegeforen 1990 0.75
128 [A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]. Tidsskr Nor Laegeforen 1994 0.75
129 Neonatal screening for hyperlipidaemia. Postgrad Med J 1975 0.75